SLR Healthcare ABL has provided a $5 million asset-based revolving credit facility for a global medical device company focused on treating cervical and lumbar spinal disease (“Company”). The Company’s product line is backed by over 30 years of clinical success and is sold through distributors in the US and internationally. The SLR credit facility will provide working capital support as the Company executes its strategic plan.

In conjunction with the asset-based revolving credit facility, the SLR platform, through its Life Science Finance team, also provided a $60 million first lien term loan to the Company. The transaction demonstrates SLR’s ability to deliver one-stop healthcare financing solutions for its clients.